top of page

Determined to make a difference for patients

Patient Access

Our core objective is to ensure that patients in need have a timely and sustained access to new, innovative medicines and technologies.

Today’s patient access environment is becoming more and more challenging. To minimize the risk of clinical uncertainties and safeguard the healthcare budget, health authorities want to see increasingly compelling evidence.

Meanwhile pharmaceutical companies want payers to look beyond price, acknowledging the value and rewarding innovation.


Axes Health was founded to overcome this patient access challenge by bridging the gap between the various stakeholders and co-creating solutions

Using a personalized and collaborative approach, we obtain clear insights in the healthcare landscape, the needs of all stakeholders and the opportunities they offer. 


A story that made a difference for patients

One of our recent success stories was to get reimbursement in Belgium for a medicine which allows patients to receive a kidney transplant. Without this innovation, these patients would reject the donor kidney and would be lifelong on dialysis.

With the support of a cross-functional team, we were able to discuss with the authorities that reimbursing this innovative treatment is not only a game changer for patients, it also saves money for the healthcare system by avoiding lifelong dialysis.

A Story of Patient Access

For example:

Acute lymphoblastic leukemia (ALL), Chronic lymphocytic leukemia (CLL), Chronic myeloid leukemia (CML), Diffuse large B cell lymphoma, multiple myeloma


For example:

Breast cancer, Cholangiocarcinoma, GIST, Ovarian cancer


For example: Alagille syndrome, Amyotrophic Lateral Sclerosis, Aromatic L-Amino Acid Decarboxylase, Cystic Fibrosis, Hereditary Angioedema, Lupus Nephritis, Myasthenia Gravis, Paroxysmal Nocturnal Hemoglobinuria, Transfusion dependent Thalassaemias, Wilson disease

Orphan indications

For example:

Kidney transplantation


For example:

Cardiovascular risk reduction


Therapeutic areas


Early dialogues

We believe in the power of discussing challenges and opportunities with relevant stakeholders, prior to the submission of an official reimbursement request. We help our clients to navigate the specific healthcare ecosystem.

Early access program

The patient's unmet medical need does not start at the time of reimbursement. That is why we help companies in setting up early access programs, so that eligible patients can start treatment prior to reimbursement.

Pricing & reimbursement

We perform a thorough  analysis of the therapeutic domain in the local market. This allows us to give strategic advice and to write a pricing and reimbursement dossier that is adapted to the specific needs.

Our Partners

bottom of page